APP and Alzheimer disease: SORCS1 has been previously implicated in neurodegeneration by genetic association with Alzheimer's disease as well as with APP processing whereby reduced expression of SORCS1 is associated with increased γ-secretase processing and Aβ levels possibly as a result of altered trafficking (28).